Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 1 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Handong Global University Industry-Academic Cooperation Foundation manages 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 4 pending office actions are distributed across 4 distinct examiners, including DURYEE, ALEXANDER MARSH, who is responsible for 1 pending office action. All current activity is concentrated within 1 distinct art unit, suggesting a unified technical focus despite the involvement of 4 distinct examiners.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DURYEE, ALEXANDER MARSH | 1 | 33.3% | +41.6% |
| JACKSON III, WALTER | 1 | 100.0% | +0.0% |
| DUFFY, CAROLINE TABANCAY | 1 | 80.2% | +18.3% |
| FAN, LYNN Y | 1 | 47.3% | +49.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856355 | EXTRACELLULAR VESICLES ISOLATED FROM MESENCHYMAL STEM CELLS DERIVED FROM CHEMICALLY-INDUCED PLURIPOTENT STEM CELLS, AND USE THEREOF | JACKSON III, WALTER | — |
| 18900878 | METHOD OF ACQUIRING HIGH-DEFINITION IMAGE AND ELECTRONIC DEVICE FOR PERFORMING THE SAME | DUFFY, CAROLINE TABANCAY | — |
| 18886703 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | FAN, LYNN Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19074320 | COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN | DURYEE, ALEXANDER MARSH | — |
| 18900878 | METHOD OF ACQUIRING HIGH-DEFINITION IMAGE AND ELECTRONIC DEVICE FOR PERFORMING THE SAME | DUFFY, CAROLINE TABANCAY | — |
| 18886703 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | FAN, LYNN Y | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19074320 | COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY OR INSULIN RESISTANCE SYNDROME COMPRISING LACTOBACILLUS PLANTARUM HAC03 AND RUTIN | DURYEE, ALEXANDER MARSH | 1657 | §103 | Final Rejection | — | Pending | Mar 08, 2025 |
| 18856355 | EXTRACELLULAR VESICLES ISOLATED FROM MESENCHYMAL STEM CELLS DERIVED FROM CHEMICALLY-INDUCED PLURIPOTENT STEM CELLS, AND USE THEREOF | JACKSON III, WALTER | — | §101§102§103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18900878 | METHOD OF ACQUIRING HIGH-DEFINITION IMAGE AND ELECTRONIC DEVICE FOR PERFORMING THE SAME | DUFFY, CAROLINE TABANCAY | — | §103§112 | Non-Final OA | — | Pending | Sep 29, 2024 |
| 18886703 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | FAN, LYNN Y | — | §103§112 | Non-Final OA | — | Pending | Sep 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial